Niels Borgstein
Corporate Officer/Principal presso ALKERMES PLC
Profilo
Niels Borgstein is a professional with a doctorate degree from the University of Groningen.
He is currently working as SVP-Late Stage Clinical Development at Alkermes Plc.
Prior to this, he worked as Senior Director at Stryker Biotech LLC, Principal at Pfizer Inc., Vice President & Head-Clinical Development at Ironwood Pharmaceuticals, Inc., and Vice President-Medical Research at Acceleron Pharma, Inc.
Posizioni attive di Niels Borgstein
| Società | Posizione | Inizio |
|---|---|---|
| ALKERMES PLC | Corporate Officer/Principal | 01/01/2021 |
Precedenti posizioni note di Niels Borgstein
| Società | Posizione | Fine |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Stryker Biotech LLC
 Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The private company is based in Hopkinton, MA. | Direttore/Membro del Consiglio | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - |
Formazione di Niels Borgstein
| University of Groningen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Stryker Biotech LLC
Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The private company is based in Hopkinton, MA. | Health Technology |
- Borsa valori
- Insiders
- Niels Borgstein
